An Clinical Trial to Evaluate the Pharmacokinetics and the Safety of NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers
Latest Information Update: 09 May 2023
At a glance
- Drugs NVP 1805 R1 (Primary) ; NVP 1805 R2 (Primary) ; NVP-1805 (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors NVP Healthcare
Most Recent Events
- 03 May 2023 Status changed from active, no longer recruiting to completed.
- 26 Mar 2023 Planned End Date changed from 1 May 2023 to 27 Mar 2023.
- 05 Jan 2023 Planned End Date changed from 15 Dec 2022 to 1 May 2023.